
### [NCIT:C27262](http://purl.obolibrary.org/obo/NCIT_C27262)
**Label:** Myelodysplastic/Myeloproliferative Neoplasm

**Subclasses:** [NCIT:C82616](http://purl.obolibrary.org/obo/NCIT_C82616) (Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis), [NCIT:C36062](http://purl.obolibrary.org/obo/NCIT_C36062) (Chronic Myelomonocytic Leukemia-2), [NCIT:C3178](http://purl.obolibrary.org/obo/NCIT_C3178) (Chronic Myelomonocytic Leukemia), [NCIT:C130035](http://purl.obolibrary.org/obo/NCIT_C130035) (Chronic Myelomonocytic Leukemia-0), [NCIT:C27780](http://purl.obolibrary.org/obo/NCIT_C27780) (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable), [NCIT:C82397](http://purl.obolibrary.org/obo/NCIT_C82397) (Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm), [NCIT:C3519](http://purl.obolibrary.org/obo/NCIT_C3519) (Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative), [NCIT:C36061](http://purl.obolibrary.org/obo/NCIT_C36061) (Chronic Myelomonocytic Leukemia-1), [NCIT:C9233](http://purl.obolibrary.org/obo/NCIT_C9233) (Juvenile Myelomonocytic Leukemia), [NCIT:C36060](http://purl.obolibrary.org/obo/NCIT_C36060) (Chronic Myelomonocytic Leukemia with Eosinophilia), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39810](http://purl.obolibrary.org/obo/NCIT_C39810) (Type 2 Renal Papillary Adenoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39809](http://purl.obolibrary.org/obo/NCIT_C39809) (Type 1 Renal Papillary Adenoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39808](http://purl.obolibrary.org/obo/NCIT_C39808) (Asymptomatic Mass))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39807](http://purl.obolibrary.org/obo/NCIT_C39807) (Mucinous Tubular and Spindle Cell Carcinoma of the Kidney))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39806](http://purl.obolibrary.org/obo/NCIT_C39806) (NONO-TFE3 Fusion Protein Expression))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39805](http://purl.obolibrary.org/obo/NCIT_C39805) (PSF-TFE3 Fusion Protein Expression))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39803](http://purl.obolibrary.org/obo/NCIT_C39803) (PRCC-TFE3 Fusion Protein Expression))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39802](http://purl.obolibrary.org/obo/NCIT_C39802) (Renal Cell Carcinoma Associated with inv(X)(p11;q12)))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39801](http://purl.obolibrary.org/obo/NCIT_C39801) (inv(X)(p11;q12)))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39800](http://purl.obolibrary.org/obo/NCIT_C39800) (Sickle Cell Trait))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39799](http://purl.obolibrary.org/obo/NCIT_C39799) (Loss of Chromosome 21))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39798](http://purl.obolibrary.org/obo/NCIT_C39798) (Loss of Chromosome 2))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q))) 39.90%


